[1] Privette Vinnedge LM, Kappes F, Nassar N, et al. Stacking the DEK: from chromatin topology to cancer stem cells[J]. Cell cycle, 2013, 12(1): 51-66.
[2] Von Lindern M, Fornerod M, Van Baal S, et al. The translocation (6; 9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA[J]. Mol cell biol, 1992, 12(4): 1687-1697.
[3] Kim DW, Chae JIL, Kim JY, et al. Proteomic analysis of apoptosis related proteins regulated by proto-oncogene protein DEK[J]. J cell biochem, 2009, 106(6): 1048-1059.
[4] Shibata T, Kokubu A, Miyamoto M, et al. DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung[J]. Oncogene, 2010, 29(33): 4671-4681.
[5] Kappes F, Damoc C, Knippers R, et al. Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK[J]. Mol cell biol, 2004, 24(13): 6011-6020.
[6] Wise-Draper TM, Allen HV, Jones EE, et al. Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions[J]. Mol cell biol, 2006, 26(20): 7506-7519.
[7] Yu L, Huang X, Zhang W, et al. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma[J]. Oncotarget, 2016, 7(18): 26844-26855.
[8] Adams AK, Hallenbeck GE, Casper KA, et al. DEK promotes HPV-positive and-negative head and neck cancer cell proliferation[J]. Oncogene, 2015, 34(7): 868-877.
[9] Datta A, Adelson ME, Mogilevkin Y, et al. Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer[J]. BMC cancer, 2011, 11: 234.
[10] Martinez-Useros J, Rodriguez-Remirez M, Borrero-Palacios A, et al. DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer[J]. BMC cancer, 2014, 14: 965.
[11] Riveiro-Falkenbach E, Ruano Y, García-Martín RM, et al. DEK oncogene is overexpressed during melanoma progression[J]. Pigment Cell Melanoma Res, 2017, 30(2):194-202. |